254 related articles for article (PubMed ID: 32759167)
1. Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.
Shimonaka S; Matsumoto SE; Elahi M; Ishiguro K; Hasegawa M; Hattori N; Motoi Y
J Biol Chem; 2020 Oct; 295(41):13996-14014. PubMed ID: 32759167
[TBL] [Abstract][Full Text] [Related]
2. Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.
Tarutani A; Miyata H; Nonaka T; Hasegawa K; Yoshida M; Saito Y; Murayama S; Robinson AC; Mann DMA; Tomita T; Hasegawa M
Brain; 2021 Sep; 144(8):2333-2348. PubMed ID: 33693528
[TBL] [Abstract][Full Text] [Related]
3. Sequence-dependent abnormal aggregation of human Tau fragment in an inducible cell model.
Liu XL; Hu JY; Hu MY; Zhang Y; Hong ZY; Cheng XQ; Chen J; Pang DW; Liang Y
Biochim Biophys Acta; 2015 Aug; 1852(8):1561-73. PubMed ID: 25912737
[TBL] [Abstract][Full Text] [Related]
4. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
5. Strain-specific clearance of seed-dependent tau aggregation by lithium-induced autophagy.
Uddin MN; Elahi M; Shimonaka S; Kakuta S; Ishiguro K; Motoi Y; Hattori N
Biochem Biophys Res Commun; 2021 Mar; 543():65-71. PubMed ID: 33517128
[TBL] [Abstract][Full Text] [Related]
6. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
7. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
8. Truncation of Tau selectively facilitates its pathological activities.
Gu J; Xu W; Jin N; Li L; Zhou Y; Chu D; Gong CX; Iqbal K; Liu F
J Biol Chem; 2020 Oct; 295(40):13812-13828. PubMed ID: 32737201
[TBL] [Abstract][Full Text] [Related]
9. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
[TBL] [Abstract][Full Text] [Related]
10. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
11. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
[TBL] [Abstract][Full Text] [Related]
12. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
13. In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.
Xu H; O'Reilly M; Gibbons GS; Changolkar L; McBride JD; Riddle DM; Zhang B; Stieber A; Nirschl J; Kim SJ; Hoxha KH; Brunden KR; Schellenberg GD; Trojanowski JQ; Lee VM
Acta Neuropathol; 2021 Feb; 141(2):193-215. PubMed ID: 33385254
[TBL] [Abstract][Full Text] [Related]
14. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
15. RNA induces unique tau strains and stabilizes Alzheimer's disease seeds.
Zwierzchowski-Zarate AN; Mendoza-Oliva A; Kashmer OM; Collazo-Lopez JE; White CL; Diamond MI
J Biol Chem; 2022 Aug; 298(8):102132. PubMed ID: 35700826
[TBL] [Abstract][Full Text] [Related]
16. Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain.
Dan A; Takahashi M; Masuda-Suzukake M; Kametani F; Nonaka T; Kondo H; Akiyama H; Arai T; Mann DM; Saito Y; Hatsuta H; Murayama S; Hasegawa M
Acta Neuropathol Commun; 2013 Aug; 1():54. PubMed ID: 24252707
[TBL] [Abstract][Full Text] [Related]
17. Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage.
Cicognola C; Satir TM; Brinkmalm G; Matečko-Burmann I; Agholme L; Bergström P; Becker B; Zetterberg H; Blennow K; Höglund K
J Alzheimers Dis; 2020; 74(4):1143-1156. PubMed ID: 32144989
[TBL] [Abstract][Full Text] [Related]
18. Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice.
Johnson NR; Condello C; Guan S; Oehler A; Becker J; Gavidia M; Carlson GA; Giles K; Prusiner SB
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11029-E11036. PubMed ID: 29203673
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
Kang SS; Liu X; Ahn EH; Xiang J; Manfredsson FP; Yang X; Luo HR; Liles LC; Weinshenker D; Ye K
J Clin Invest; 2020 Jan; 130(1):422-437. PubMed ID: 31793911
[TBL] [Abstract][Full Text] [Related]
20. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
